Vertex Pharmaceuticals Incorporated VRTX
Set alert
553.15 USD -5.73 -1.03%
At close
564.30 +11.15 +2.02%
Pre-market · Nov 3, 7:16 AM ET
544.09 Day range 568.67
403.16 52-week range 568.67
- YTD
- +22.01%
- 1 year
- +29.98%
- Open
- 560.88
- Prev close
- 558.88
- Mkt cap
- 140.20B
- Vol
- 3.21M
- Avg vol
- 1.22M
- EPS
- 17.17
- P/E
- 32.22
- Div yield
- 0.00%
More statistics
- Low
- 544.09
- High
- 568.67
- Forward P/E
- 27.09
- Beta
- 0.28
- Short ratio
- 3.66
- Inst. own
- 98.10%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 11, 2027
- 50-d avg
- 523.21
- 200-d avg
- 479.21
- 1y target
- 571.46
MAX chart
Events in this range
- Nov 3, 2025Earnings: 4.8; estimate 4.57; surprise 5.03%
- May 4, 2026Earnings: 4.47; estimate 4.24; surprise 5.42%
- Aug 3, 2026Earnings: 4.73; estimate 4.74; surprise -0.21%
- Aug 4, 2026Rating: Cantor Fitzgerald · Overweight → Overweight
- Aug 4, 2026Rating: TD Cowen · Buy → Buy
- Aug 5, 2026Rating: Barclays · Overweight → Overweight
- Aug 5, 2026Rating: Truist Securities · Buy → Buy
- Nov 2, 2026Earnings: 4.76; estimate 4.82; surprise -1.24%
Signals (166)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Aug 1, 2026 | 3 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 1, 2026 | 6 months ago |
| SMA: Bearish | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Apr 1, 2026 | 7 months ago |
| SMA: Bullish | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Oct 1, 2025 | 1 year ago |
| SMA: Bearish | Aug 1, 2025 | 1 year ago |
| SMA: Bearish | May 1, 2025 | 1 year ago |
| SMA: Bullish | Jan 1, 2025 | 1 year ago |
| SMA: Bearish | Dec 1, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 1, 2024 | 1 year ago |
| RSI: Overbought | May 1, 2024 | 2 years ago |
| RSI: Overbought | Dec 1, 2023 | 2 years ago |
| SMA: Bullish | Mar 1, 2023 | 3 years ago |
| SMA: Bearish | Feb 1, 2023 | 3 years ago |
| RSI: Overbought | Oct 1, 2022 | 4 years ago |
| MACD: Buy Signal | Mar 1, 2022 | 4 years ago |
| SMA: Bullish | Jan 1, 2022 | 4 years ago |
| SMA: Bullish | Dec 1, 2021 | 4 years ago |
Newest 20 of 166.
Analyst view
Consensus: buy
Buy
Price target (mean) 571.46 +3.3% upside
Now 553.15
- Target (low)
- 350.00
- Target (mean)
- 571.46
- Target (high)
- 667.00
Ratings (0m) 32 26 buy · 4 hold · 2 sell
- Strong buy6
- Buy20
- Hold4
- Sell1
- Strong sell1
Recommendation trend
- This month 32
- 1 month ago 32
- 2 months ago 29
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 4.78 | 3.68 – 5.25 | 4.80 | -0.3% | 3.43B | +11.7% | 13 |
| Next quarter | 4.64 | 4.04 – 5.22 | 5.03 | -7.7% | 3.53B | +10.7% | 16 |
| Current year | 18.77 | 17.61 – 19.54 | 18.40 | +2.0% | 13.28B | +10.7% | 17 |
| Next year | 20.42 | 17.86 – 23.06 | 18.77 | +8.8% | 14.60B | +9.9% | 19 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 28, 2026 | UBS | Maintained | Buy | Buy |
| Aug 5, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 5, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 4, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 4, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Jul 13, 2026 | UBS | Maintained | Buy | Buy |
| Jul 13, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 7, 2026 | Baird | Maintained | Underperform | Underperform |
| May 6, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 5, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| May 5, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| May 5, 2026 | Bernstein | Maintained | Outperform | Outperform |
| May 5, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Apr 30, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Apr 10, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Mar 18, 2026 | Maxim Group | Upgrade | Hold | Buy |
| Mar 11, 2026 | Truist Securities | Maintained | Buy | Buy |
| Mar 10, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Mar 10, 2026 | B of A Securities | Maintained | Buy | Buy |
| Mar 10, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 10, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Mar 10, 2026 | Jefferies | Initiated | — | Buy |
| Mar 10, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 17, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Feb 17, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 17, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 13, 2026 | Scotiabank | Maintained | Sector Perform | Sector Perform |